≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Conductive hearing loss, unspecified

EFO MESH Endpoint Browser PheWeb

H8_HL_CON_NAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H90.0, H90.1, H90.2
  • Hospital discharge: ICD-9 — 3890
  • Cause of death: ICD-10 — H90.0, H90.1, H90.2
  • Cause of death: ICD-9 — 3890

2 out of 7 registries used, show all original rules.

3426

4. Check minimum number of events

None

3426

5. Include endpoints

None

3426

6. Filter based on genotype QC (FinnGen only)

3426

Control definitions (FinnGen only)

Control exclude
H8_OTHEREAR

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 29372 15605 13612
Only index persons 27163 14637 12526
Unadjusted period prevalence (%)
Whole population 0.41 0.45 0.38
Only index persons 0.51 0.54 0.48
Median age at first event (years)
Whole population 47.02 48.69 45.13
Only index persons 47.49 49.19 45.51

-FinnGen-

Key figures

All Female Male
Number of individuals 3426 1986 1440
Unadjusted period prevalence (%) 0.66 0.68 0.63
Median age at first event (years) 53.03 50.98 55.86

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3083
Matched controls
30827
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
148.5
323.0
1108
116
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
1500.5
323.0
866
8
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
1209.6
323.0
419
*
DFF00
NOMESCO Finland
Pure tone audiometry
35.6
323.0
996
408
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
265.5
323.0
353
15
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
97.9
323.0
363
42
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
+∞
323.0
336
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
44.6
323.0
474
125
Z01.1
ICD-10 Finland
Examination of ears and hearing
17.9
323.0
1273
1162
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
9443.9
323.0
2076
8
UDC00
NOMESCO Finland
Ear microscopy
15.2
323.0
745
632
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
118.1
313.5
337
32
H80.9
ICD-10 Finland
Otosclerosis, unspecified
81.9
312.0
350
48
DDA00
NOMESCO Finland
Stapedotomy
115.5
297.8
321
31
DFF15
NOMESCO Finland
Speech audiometry
40.4
294.6
374
105
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
526.2
293.7
288
6
Z97.4
ICD-10 Finland
Presence of external hearing-aid
50.0
269.1
327
73
DC1AD
NOMESCO Finland
Temporalbone CT
61.7
239.9
281
50
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
36.4
217.1
282
85
DAX08
NOMESCO Finland
Fitting of hearing aid
54.3
208.8
250
50
Z3229
NOMESCO Finland
Other healthcare associate professional
6.5
196.3
559
1011
H71
ICD-10 Finland
Cholesteatoma of middle ear
47.9
188.6
231
52
R5120
NOMESCO Finland
Preparation of an aid
29.5
181.4
248
91
H91.9
ICD-10 Finland
Hearing loss, unspecified
18.1
166.7
266
160
H02
ICPC
Hearing complaint
5.6
157.8
507
1048
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
124.4
153.8
165
14
H93.1
ICD-10 Finland
Tinnitus
12.2
152.3
288
259
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
43.2
149.7
187
46
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
17.4
139.2
225
139
DCD10
NOMESCO Finland
Tympanoplasty
153.1
138.6
146
10
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
126.6
560
1588
H65.3
ICD-10 Finland
Chronic mucoid otitis media
11.0
122.2
242
237
ZXC10
NOMESCO Finland
Use of laser
11.1
116.6
230
223
N07CA01
ATC
betahistine; oral
5.7
114.6
353
680
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
9.1
104.7
230
271
H91.1
ICD-10 Finland
Presbycusis
10.7
90.3
180
177
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
12.0
85.6
161
141
H80.1
ICD-10 Finland
Otosclerosis involving oval window, obliterative
106.5
85.4
93
9
SPAT1043
SPAT
Audiometry
4.1
83.6
354
942
TDA90
NOMESCO Finland
Removal wax from ear
18.1
77.3
122
70
R5140
NOMESCO Finland
Monitoring the use of the aid
3.3
75.5
423
1412
R4135
NOMESCO Finland
Rehabilitation for hearing problems
62.4
72.9
85
14
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
101.3
72.2
79
8
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
114.3
72.2
78
7
H66.0
ICD-10 Finland
Acute suppurative otitis media
3.7
69.3
329
962
H74.1
ICD-10 Finland
Adhesive middle ear disease
45.4
68.3
84
19
3890A
ICD-9 Finland
Deafness, Conductive deafness
+∞
65.9
63
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
25.6
65.3
92
37
DCD00
NOMESCO Finland
Myringoplasty
23.5
60.4
87
38
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
64.1
59.6
69
11
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
21.6
56.8
84
40
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
56.4
54
*
H65.2
ICD-10 Finland
Chronic serous otitis media
9.8
55.7
115
121
H60.9
ICD-10 Finland
Otitis externa, unspecified
3.5
54.0
274
840
H80.8
ICD-10 Finland
Other otosclerosis
139.9
52.0
55
*
H29
ICPC
Ear symptom/complaint other
2.9
50.5
343
1289
H66.9
ICD-10 Finland
Otitis media, unspecified
3.5
50.2
254
776
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
134.7
49.9
53
*
H60.3
ICD-10 Finland
Other infective otitis externa
6.8
47.1
122
185
DCA30
NOMESCO Finland
Exploration of middle ear
165.9
47.0
49
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
15.4
46.8
78
52
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
13.9
45.6
79
58
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.0
45.4
151
312
H81.0
ICD-10 Finland
Ménière disease
7.5
44.2
107
147
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
30.0
44.0
59
20
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
33.5
42.9
56
17
DFE00
NOMESCO Finland
Insertion of cochlear implant
+∞
42.8
41
*
DDB00
NOMESCO Finland
Stapedectomy
79.6
42.0
47
6
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
40.3
255
909
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
74.5
39.0
44
6
H80
ICD-10 Finland
Otosclerosis
138.4
38.8
41
*
H92.0
ICD-10 Finland
Otalgia
3.6
38.5
181
520
R42
ICD-10 Finland
Dizziness and giddiness
2.0
37.9
607
3441
H70.1
ICD-10 Finland
Chronic mastoiditis
26.4
37.6
52
20
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
8.4
37.6
84
102
DEA10
NOMESCO Finland
Attico-antrotomy
39.8
37.5
47
12
H60.8
ICD-10 Finland
Other otitis externa
4.9
36.3
124
264
H61.2
ICD-10 Finland
Impacted cerumen
3.1
35.6
204
681
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
13.1
35.6
63
49
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
32.6
34.4
45
14
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
34.3
838
5455
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
25.1
33.6
47
19
S02CA02
ATC
flumetasone and antiinfectives; otic
2.9
32.6
207
740
H91.8
ICD-10 Finland
Other specified hearing loss
15.8
32.5
53
34
ZXA00
NOMESCO Finland
Right side
1.7
32.3
789
5116
H13
ICPC
Plugged feeling ear
1.9
31.3
493
2758
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
21.2
31.3
46
22
RK520
NOMESCO Finland
NA
29.6
30.7
41
14
ZXA05
NOMESCO Finland
Left side
1.7
30.5
727
4668
H65.0
ICD-10 Finland
Acute serous otitis media
5.9
30.5
87
151
DGW00
NOMESCO Finland
Dilatation of eustachian tube
52.0
30.3
36
7
H01
ICPC
Ear pain/earache
2.2
30.3
331
1591
J01CA04
ATC
amoxicillin; systemic
1.7
30.1
2398
20945
4122
FHL
Tympanostomy (tympanic tube)
5.8
30.0
87
154
38699
ICD-8 Finland
NA
20.3
29.6
44
22
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
6.3
29.1
79
129
3870A
ICD-9 Finland
Otosclerosis involving oval window, nonobliterative
23.1
28.7
41
18
R01AD09
ATC
mometasone; nasal
1.6
28.6
1260
9488
4133
FHL
Stapedectomy sampling
29.6
28.5
38
13
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
28.2
27
*
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
9.5
27.6
57
61
DEB30
NOMESCO Finland
Radical mastoidectomy
47.6
27.4
33
7
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
+∞
27.1
26
*
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
21.9
26.9
39
18
RK320
NOMESCO Finland
NA
10.0
26.4
53
54
H91
ICD-10 Finland
Other hearing loss
13.3
26.4
46
35
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
26.3
1453
11445
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.8
25.9
492
2923
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
15.7
25.9
42
27
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
27.2
25.8
35
13
H74.3
ICD-10 Finland
Other acquired abnormalities of ear ossicles
94.2
25.7
28
*
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
16.0
25.4
41
26
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
7.3
25.2
61
85
DFX00
NOMESCO Finland
Connecting cochlear implant
+∞
25.0
24
*
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
23.6
24.8
35
15
H81
ICPC
Excessive ear wax
1.9
24.2
411
2348
H04
ICPC
Ear discharge
3.6
24.1
110
310
DCB10
NOMESCO Finland
Freeing of adhesions of middle ear
+∞
24.0
23
*
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
241.7
23.7
24
*
WX110
NOMESCO Finland
Local anesthesy
1.5
22.8
1946
16571
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
40.4
22.7
28
7
DDD10
NOMESCO Finland
Interposition between malleus and stapes
231.6
22.6
23
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
20.8
22.5
33
16
YPA00
NOMESCO Finland
Excision of blood vessel for transplantation
115.8
21.6
23
*
ZXA10
NOMESCO Finland
Bilateral
1.7
21.6
515
3270
R01AD08
ATC
fluticasone; nasal
1.5
21.1
766
5422
N02BE01
ATC
paracetamol; systemic, rectal
1.5
20.9
2441
21970
RK110
NOMESCO Finland
NA
8.3
20.9
46
56
DDA10
NOMESCO Finland
Exploration of ossicular chain
+∞
20.9
20
*
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
14.9
20.7
34
23
J01DB01
ATC
cefalexin; oral
1.5
20.3
2348
20989
H84
ICPC
Presbyacusis
4.6
20.0
70
155
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
19.9
193
873
H90
ICD-10 Finland
Conductive and sensorineural hearing loss
36.0
19.8
25
7
H73.1
ICD-10 Finland
Chronic myringitis
46.3
19.2
23
5
H81.3
ICD-10 Finland
Other peripheral vertigo
3.5
19.2
89
256
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
18.9
989
7545
DDD20
NOMESCO Finland
Interposition between eardrum and footplate of stapes
+∞
18.8
18
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
12.4
18.1
32
26
Q17.2
ICD-10 Finland
Microtia
52.8
17.9
21
*
H28
ICPC
Limited function/disability (H)
8.7
17.9
38
44
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.8
17.7
75
200
Q16.3
ICD-10 Finland
Congenital malformation of ear ossicles
+∞
17.7
17
*
RK420
NOMESCO Finland
NA
67.0
17.7
20
*
R51.80
ICD-10 Finland
Headache
1.7
17.7
396
2457
AA1AD
NOMESCO Finland
CT of head and brain
1.6
17.7
576
3946
1450
FHL
Otomicroscopy
9.8
17.6
35
36
RK120
NOMESCO Finland
NA
21.0
17.3
25
12
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
17.1
1046
8180
SPAT1352
SPAT
Inspection, maintenance and instruction for use of hearing aid
8.9
17.1
36
41
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
17.1
554
3787
H61.8
ICD-10 Finland
Other specified disorders of external ear
5.6
16.9
49
89
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
+∞
16.7
16
*
H60
ICD-10 Finland
Otitis externa
2.5
16.6
132
541
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
3.2
16.2
84
264
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
16.8
16.1
25
15
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
47.7
16.0
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.5
15.7
728
5377
WX002
NOMESCO Finland
Sedation and analgesia
1.6
15.5
510
3492
4151
FHL
Reoperation for chronic otitis media
160.7
15.5
16
*
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.7
15.3
51
109
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.9
15.2
214
1138
J01MA02
ATC
ciprofloxacin; systemic
1.4
15.1
971
7622
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
15.0
1936
17041
J01DA01
ATC
[U] cefalexin; systemic
1.4
15.0
1691
14567
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
14.9
599
4287
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
14.9
923
7190
UDC10
NOMESCO Finland
Tympanoscopy
56.9
14.8
17
*
H02AB06
ATC
prednisolone; systemic
1.4
14.7
1207
9864
H80.20
ICD-10 Finland
Otosclerosis involving round window
+∞
14.6
14
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
80.5
14.6
16
*
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.9
14.6
233
1296
4161
FHL
Exploratory tympanotomy
150.7
14.5
15
*
DFF59
NOMESCO Finland
Other assessment of balance
6.1
13.9
37
61
S02.11
ICD-10 Finland
Fracture of base of skull, open
15.8
13.9
22
14
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
12.7
13.9
24
19
H83.1
ICD-10 Finland
Labyrinthine fistula
30.2
13.9
18
6
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
53.6
13.8
16
*
DDW99
NOMESCO Finland
Other operation on ossicles of ear
53.6
13.8
16
*
Q78.00
ICD-10 Finland
Congenital osteogenesis imperfecta
75.5
13.6
15
*
H74.0
ICD-10 Finland
Tympanosclerosis
75.5
13.6
15
*
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
6.6
13.5
34
52
DFF16
NOMESCO Finland
Speech-in-noise audiometry
140.6
13.5
14
*
H66
ICD-10 Finland
Suppurative and unspecified otitis media
2.9
13.2
79
277
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
40.2
13.1
16
*
R06.0
ICD-10 Finland
Dyspnoea
1.5
13.1
595
4357
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
13.1
202
1112
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.5
13.0
433
2963
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.5
12.7
417
2845
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
12.7
1027
8324
J01FA10
ATC
azithromycin; systemic
1.3
12.7
1567
13534
A02BC05
ATC
esomeprazole; systemic
1.3
12.4
1019
8271
38199
ICD-8 Finland
Otitis media without mention of mastoiditis, Unspecified
11.7
12.3
22
19
M79.6
ICD-10 Finland
Pain in limb
1.4
12.3
892
7096
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
12.1
1120
9245
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
12.1
764
5935
4145
FHL
Tympanomastoidectomy, includes possible tympanoplasty
21.4
12.0
17
8
J01AA02
ATC
doxycycline; systemic
1.3
12.0
2103
19035
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
11.9
705
5408
A98
ICPC
Health maint/preventive medicine
1.6
11.9
2850
27243
A02BC03
ATC
lansoprazole; oral
1.4
11.9
713
5487
A02BC02
ATC
pantoprazole; systemic
1.3
11.6
1678
14731
R5599
NOMESCO Finland
Other rehabilitation service
2.7
11.5
76
283
R01AD12
ATC
fluticasone furoate; nasal
1.4
11.5
735
5714
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
11.5
11
*
3891A
ICD-9 Finland
Deafness, Sensorineural deafness
+∞
11.5
11
*
EMB30
NOMESCO Finland
Adenotomy
2.5
11.5
85
340
Z71.8
ICD-10 Finland
Other specified counselling
1.4
11.3
599
4502
RK290
NOMESCO Finland
NA
11.8
11.3
20
17
Z96.2
ICD-10 Finland
Presence of otological and audiological implants
35.1
11.3
14
*
D33.30
ICD-10 Finland
Acoustic neuroma
10.6
11.2
21
20
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
11.2
1430
12316
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
11.0
1067
8835
G47.3
ICD-10 Finland
Sleep apnoea
1.4
11.0
490
3563
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
10.9
1745
15467
SPAT1301
SPAT
No procedures
1.4
10.8
775
6129
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
7.2
10.7
25
35
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
21.5
10.7
15
7
DC1AI
NOMESCO Finland
Cone beam CT of ear
60.2
10.6
12
*
RK530
NOMESCO Finland
NA
60.2
10.6
12
*
S02.10
ICD-10 Finland
Fracture of base of skull, closed
8.0
10.6
23
29
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
10.5
1061
8824
R03AC02
ATC
salbutamol; inhalant
1.3
10.5
1374
11837
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
10.5
1152
9696
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
10.4
1237
10521
P20
ICPC
Memory disturbance
1.6
10.4
242
1516
H92.1
ICD-10 Finland
Otorrhoea
16.1
10.3
16
10
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.0
10.3
138
723
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.4
10.2
83
349
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
4.1
10.1
38
94
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
10.1
935
7669
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
9.9
182
1061
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
9.9
245
1560
N03AX16
ATC
pregabalin; oral
1.4
9.8
554
4205
4144
FHL
Mastoidectomy or aticomastoidectomy
20.1
9.8
14
7
DC1BD
NOMESCO Finland
Temporal bone extensive CT
20.1
9.8
14
7
N03AX12
ATC
gabapentin; oral
1.5
9.8
353
2455
DBB00
NOMESCO Finland
Excision of lesion of external auditory canal
10.6
9.8
18
17
Z3231
NOMESCO Finland
Registered nurse
1.3
9.7
706
5579
DEB35
NOMESCO Finland
Radical mastoidectomy with tympanoplasty
55.2
9.6
11
*
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
15.1
9.5
15
10
DBD30
NOMESCO Finland
Correction of atresia of external auditory canal
100.3
9.4
10
*
38299
ICD-8 Finland
Unspecified otitis media with mastoiditis
100.3
9.4
10
*
N06AX11
ATC
mirtazapine; oral
1.3
9.4
769
6186
ZXD20
NOMESCO Finland
Day surgery
1.5
9.4
327
2258
38990
ICD-8 Finland
Other deafness, Partialis uni-sive bilateralis
+∞
9.4
9
*
3851A
ICD-9 Finland
Other disorders of middle ear and mastoid, Adhesive middle ear disease
+∞
9.4
9
*
H91.0
ICD-10 Finland
Ototoxic hearing loss
+∞
9.4
9
*
DDD30
NOMESCO Finland
Fixation of tympanic membrane to stapes
+∞
9.4
9
*
S18
ICPC
Laceration/cut
1.3
9.3
1023
8567
J01DA08
ATC
[U] cefaclor; oral
1.5
9.3
292
1967
G44.2
ICD-10 Finland
Tension-type headache
1.5
9.3
300
2039
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
9.2
497
3740
M25.5
ICD-10 Finland
Pain in joint
1.3
9.0
684
5431
H02AB04
ATC
methylprednisolone; systemic
1.5
9.0
343
2416
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
8.9
512
3889
4451
FHL
Guitar cutting
2.3
8.9
77
336
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.0
8.9
104
519
R1260
NOMESCO Finland
Evaluation of communicative skills
3.1
8.8
47
155
J35.2
ICD-10 Finland
Hypertrophy of adenoids
2.6
8.8
64
254
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
8.8
1860
16851
M54.5
ICD-10 Finland
Low back pain
1.3
8.8
778
6319
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
8.7
615
4831
Z2446
NOMESCO Finland
Social worker
1.7
8.7
173
1035
DCB00
NOMESCO Finland
Excision of lesion of middle ear
50.1
8.7
10
*
H73.8
ICD-10 Finland
Other specified disorders of tympanic membrane
50.1
8.7
10
*
Z2221
NOMESCO Finland
Medical doctor
1.3
8.7
718
5773
R01AD01
ATC
beclometasone; nasal
1.4
8.6
358
2561
R06.5
ICD-10 Finland
Mouth breathing
1.6
8.6
202
1268
M03BX02
ATC
tizanidine; oral
1.3
8.5
1567
13945
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
27.6
8.5
11
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
8.5
417
3081
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
8.5
368
2660
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
8.4
1369
12003
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
8.4
510
3910
Z45.3
ICD-10 Finland
Adjustment and management of implanted hearing device
+∞
8.3
8
*
75650
ICD-8 Finland
Other congenital anomalies of musculoskeletal system, Chondrodystrophy
+∞
8.3
8
*
38799
ICD-8 Finland
Other disease of ear and mastoid process, Other
+∞
8.3
8
*
ZXE00
NOMESCO Finland
One hour or less
1.3
8.3
1015
8591
L12
ICPC
Hand/finger symptom/complaint
1.5
8.3
330
2344
R05
ICPC
Cough
1.4
8.2
528
4079
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.2
577
4524
R05
ICD-10 Finland
Cough
1.4
8.0
443
3339
KMAK
NOMESCO Finland
NA
1.2
8.0
1313
11502
H60.4
ICD-10 Finland
Cholesteatoma of external ear
7.2
7.9
18
25
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
7.9
220
1444
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
7.9
174
1076
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
7.9
660
5306
H72
ICD-10 Finland
Perforation of tympanic membrane
13.0
7.9
13
10
DFF20
NOMESCO Finland
Audiometry for children
13.0
7.9
13
10
RK220
NOMESCO Finland
NA
6.1
7.8
20
33
M79.1
ICD-10 Finland
Myalgia
1.5
7.8
284
1977
Z98.8
ICD-10 Finland
Other specified postsurgical states
3.2
7.8
38
119
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
7.8
209
1361
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
7.8
142
831
SPAT1041
SPAT
Comprehensive hearing test
4.1
7.8
28
68
Z3226
NOMESCO Finland
Physiotherapist
1.4
7.7
452
3442
T16
ICD-10 Finland
Foreign body in ear
4.2
7.7
27
64
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.6
7.6
173
1079
R53
ICD-10 Finland
Malaise and fatigue
1.4
7.6
462
3538
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
7.6
685
5564
DFX03
NOMESCO Finland
Review, maintenance and user education for hearing aid
25.1
7.6
10
*
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
7.5
976
8304
Z01.2
ICD-10 Finland
Dental examination
1.3
7.4
1039
8908
Q78.08
ICD-10 Finland
Osteogenesis imperfecta tarda
80.3
7.4
8
*
4146
FHL
Radical cutting (bridge broken)
80.3
7.4
8
*
Q16.0
ICD-10 Finland
Congenital absence of (ear) auricle
80.3
7.4
8
*
H74.4
ICD-10 Finland
Polyp of middle ear
80.3
7.4
8
*
H80.28
ICD-10 Finland
Cochlear otosclerosis
80.3
7.4
8
*
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.5
7.4
229
1542
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
7.4
368
2723
A28
ICPC
Limited function/disability NOS
1.5
7.4
294
2087
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
7.4
284
2003
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
7.3
103
553
RK240
NOMESCO Finland
NA
+∞
7.3
7
*
DFF40
NOMESCO Finland
Otoneurologic examination of vertigo
10.9
7.3
13
12
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.2
7.3
71
328
R4130
NOMESCO Finland
Speech therapy
2.5
7.2
54
219
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
15.8
7.2
11
7
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
7.2
814
6798
T90.5
ICD-10 Finland
Sequelae of intracranial injury
3.4
7.2
32
94
4143
FHL
Atticotomy or atticoanthromy through the ear canal
30.1
7.1
9
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
7.1
403
3049
ZZG00
NOMESCO Finland
Graft of cartilage
12.0
7.1
12
10
SPAT1044
SPAT
Tympanometry
2.5
7.1
53
216
R06AE07
ATC
cetirizine; oral
1.2
7.0
1085
9396
K02.1
ICD-10 Finland
Caries of dentine
1.2
7.0
1465
13102
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.6
7.0
171
1086
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
4.1
7.0
25
61
SPAT1153
SPAT
Removal of sutures
1.3
6.9
736
6094
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
6.9
480
3748
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
6.9
2502
23748
N17
ICPC
Vertigo/dizziness
1.5
6.9
227
1553
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.3
6.8
593
4786
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.2
6.8
938
8012
H03
ICPC
Tinnitus, ringing/buzzing ear
3.0
6.8
37
126
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
6.8
106
591
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.7
6.8
138
838
R4110
NOMESCO Finland
Physiotherapy
1.3
6.7
642
5243
H70.0
ICD-10 Finland
Acute mastoiditis
16.7
6.7
10
6
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.0
6.7
82
420
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.3
6.7
767
6409
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.1
6.7
72
348
L03
ICPC
Low back symptom/complaint
1.3
6.7
544
4349
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
6.7
165
1055
H02AB07
ATC
prednisone; oral
1.4
6.7
325
2398
R21
ICPC
Throat symptom/complaint
1.3
6.7
472
3698
Z2445
NOMESCO Finland
Psychologist
1.8
6.6
101
559
L28
ICPC
Limited function/disability (L)
1.4
6.6
328
2429
E0000UV
ATC
NA
1.2
6.6
959
8238
H70
ICPC
Otitis externa
2.5
6.5
48
196
H69.0
ICD-10 Finland
Patulous Eustachian tube
4.8
6.5
20
42
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.3
6.5
519
4135
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.4
6.5
252
1783
H91.3
ICD-10 Finland
Deaf mutism, not elsewhere classified
70.0
6.4
7
*
M01AE02
ATC
naproxen; oral, rectal
1.2
6.4
1456
13088
R06AX27
ATC
desloratadine; oral
1.3
6.4
644
5293
UKC02
NOMESCO Finland
Cystoscopy
1.4
6.4
329
2448
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
6.4
1053
9160
Z31.5
ICD-10 Finland
Genetic counselling
1.7
6.4
117
687
J02AC01
ATC
fluconazole; systemic
1.2
6.4
957
8238
R03BA02
ATC
budesonide; inhalant
1.3
6.4
405
3122
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.2
6.3
60
276
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
6.3
638
5240
SPAT1053
SPAT
Memory test
1.4
6.3
273
1971
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.9
6.3
86
458
R13
ICD-10 Finland
Dysphagia
1.6
6.2
138
858
SPAT1216
SPAT
Assessment of functional ability
1.4
6.2
316
2345
4129
FHL
Other measure in this category
26.7
6.2
8
*
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
26.7
6.2
8
*
J01DA06
ATC
[U] cefuroxime; systemic
1.4
6.2
342
2578
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
6.2
1445
13004
A02BC01
ATC
omeprazole; systemic
1.3
6.2
632
5198
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.2
419
3261
M02AA07
ATC
piroxicam; topical
1.2
6.2
837
7124
J45.9
ICD-10 Finland
Asthma, unspecified
1.3
6.2
403
3118
D07AC13
ATC
mometasone; topical
1.3
6.1
662
5483
R12
ICD-10 Finland
Heartburn
1.6
6.1
154
988
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
3.4
6.1
27
80
D07AC01
ATC
betamethasone; topical
1.2
6.1
802
6799
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.2
6.1
740
6217
Z01.9
ICD-10 Finland
Special examination, unspecified
1.7
6.1
123
744
S82
ICPC
Naevus/mole
1.4
6.1
269
1952
J01FA09
ATC
clarithromycin; systemic
1.2
6.1
752
6328
SPAT1312
SPAT
General health counselling
1.2
6.1
780
6593
RK510
NOMESCO Finland
NA
12.5
6.1
10
8
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.1
721
6044
R49.01
ICD-10 Finland
Functional dysphonia
2.1
6.1
65
315
Z97.8
ICD-10 Finland
Presence of other specified devices
8.6
6.0
12
14
H25.8
ICD-10 Finland
Other senile cataract
1.5
6.0
198
1355

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
605
3144
2.12
55.41
2.1
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2329
20233
1.47
23.44
4.3
4.0
mm/h
12.1
11.9
0.21
2174
18734
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1350
10697
1.43
21.83
2.0
2.0
pmol/l
96.3
94.8
0.48
689
5566
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1486
12053
1.41
20.73
6.9
6.1
mmol/l
1.2
1.2
0.67
1362
10958
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2381
20992
1.44
20.43
7.6
7.4
u/l
77.5
78.9
0.74
2236
19818
(3019550) Sodium [Moles/volume] in Serum or Plasma
3046
28340
1.67
19.57
17.8
15.4
mmol/l
139.8
139.7
2.58
2979
27626
(3023103) Potassium [Moles/volume] in Serum or Plasma
3051
28426
1.67
19.15
18.0
15.5
mmol/l
4.0
4.0
0.29
2982
27658
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1596
13310
1.37
17.90
7.3
6.8
mmol/l
1.2
1.2
0.52
1376
11264
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1066
8345
1.40
17.45
2.8
2.6
u/l
56.6
57.6
0.24
988
7715
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3135
29551
1.72
17.15
11.1
10.1
u/l
26.1
26.5
0.54
3031
28571
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2865
26449
1.51
17.11
4.6
4.3
mmol/l
5.9
5.9
0.86
2621
24214
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2770
25409
1.47
16.99
5.1
4.6
mu/l
1.9
2.1
1.37
2543
23386
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2390
21391
1.39
16.54
4.3
3.9
pmol/l
14.7
14.7
0.28
2181
19542
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2979
27802
1.55
16.16
15.6
13.6
mg/l
22.6
23.7
1.04
2386
21885
(3037467) Urinalysis macro (dipstick) panel - Urine
2138
18846
1.36
15.95
4.7
4.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3082
29031
1.61
15.56
14.6
12.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1842
15933
1.34
15.25
5.5
4.7
mmol/l
6.6
6.7
0.43
1726
14852
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1193
9700
1.35
14.88
3.8
3.4
ng/l
41.8
98.3
0.59
758
6371
(3042936) Bacteria identified in Isolate by Culture
526
3760
1.47
13.76
1.9
2.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3247
31134
1.82
13.74
22.9
19.9
e9/l
252.9
253.0
0.04
3171
30349
(3021960) Folate [Moles/volume] in Serum or Plasma
776
5956
1.39
13.69
1.6
1.5
nmol/l
21.1
20.4
0.61
663
5122
(3024731) MCV [Entitic volume]
3248
31152
1.82
13.65
22.7
19.9
fl
90.8
90.8
0.11
3204
30732
(3035941) MCH [Entitic mass]
3248
31154
1.82
13.62
22.7
19.8
pg
30.2
30.3
0.21
3203
30731
(3026361) Erythrocytes [#/volume] in Blood
3248
31158
1.82
13.55
22.8
19.9
e12/l
4.5
4.5
1.03
3167
30294
(3010813) Leukocytes [#/volume] in Blood
3248
31167
1.81
13.41
22.9
20.0
e9/l
6.7
6.7
0.38
3167
30295
(3000963) Hemoglobin [Mass/volume] in Blood
3248
31168
1.81
13.40
23.0
20.0
g/l
134.8
135.4
1.44
3202
30743
(3031040) Bacteria [#/volume] in Urine by Automated count
2026
17961
1.31
13.15
4.6
4.3
e6/l
1057.5
1589.4
0.26
28
244
(3013115) Eosinophils [#/volume] in Blood
1663
14400
1.30
12.63
6.6
6.2
e9/l
0.2
0.2
0.11
1494
12595
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
983
7935
1.33
12.35
2.3
2.1
u/l
215.1
228.0
0.15
919
7461
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1624
14072
1.29
12.05
6.3
6.2
umol/l
10.8
11.4
1.06
1540
13348
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1328
11210
1.30
12.02
2.5
2.3
nmol/l
76.7
76.6
0.07
1196
10141
(3032080) INR in Blood by Coagulation assay
1256
10524
1.31
12.02
8.2
9.2
inr
1.2
1.2
2.11
334
3079
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2778
25909
1.38
11.99
13.8
12.6
ml/min/173m2
82.6
83.0
0.34
2294
21255
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2679
24855
1.36
11.86
5.8
5.5
mmol/mol
39.4
39.6
0.39
2476
23111
(3001604) Monocytes [#/volume] in Blood
1600
13885
1.29
11.54
6.3
5.9
e9/l
0.6
0.6
0.63
1423
11939
(3006315) Basophils [#/volume] in Blood
1605
13936
1.29
11.52
6.4
6.0
e9/l
0.0
0.0
0.36
1427
11983
(3015736) pH of Urine
1237
10388
1.30
11.50
3.5
3.2
—
5.8
—
0
9
(3000494) Fungus identified in Specimen by Culture
437
3136
1.45
11.07
1.5
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1636
14323
1.27
10.67
6.4
6.0
e9/l
1.9
1.9
1.56
1487
12574
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2049
18446
1.28
10.58
3.3
3.1
u/l
44.5
47.4
0.86
1917
17256
(3019309) Folate [Moles/volume] in Red Blood Cells
611
4684
1.37
10.56
1.7
1.7
nmol/l
1160.9
1168.7
0.07
453
3555
(3006504) Eosinophils/100 leukocytes in Blood
1505
13107
1.26
10.03
6.6
6.1
%
2.9
2.8
0.36
1419
12233
(3019069) Monocytes/100 leukocytes in Blood
1512
13178
1.26
10.00
6.9
6.4
%
8.7
8.6
0.67
1430
12354
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
871
7090
1.31
9.93
3.3
3.0
ng/l
1527.1
1446.5
0.15
727
6071
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
604
4667
1.36
9.87
1.3
1.3
iu/ml
30.6
32.4
0.09
171
1486
(3018418) pH of Serum or Plasma
961
7941
1.29
9.75
4.1
4.0
ph
7.4
7.4
0.23
148
1514
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2907
27536
1.37
9.58
5.1
4.7
mmol/l
2.8
2.8
0.10
2686
25481
(3022096) Basophils/100 leukocytes in Blood
1462
12735
1.26
9.58
6.6
6.2
%
0.7
0.7
0.37
1372
11895
(3037522) Nuclear Ab [Titer] in Serum
494
3716
1.38
9.53
1.4
1.3
titre
611.1
524.9
0.42
94
774
(3018010) Neutrophils/100 leukocytes in Blood
1524
13369
1.25
9.29
6.4
6.0
%
56.7
56.9
0.29
1437
12542
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
572
4428
1.35
9.19
1.4
1.2
u/ml
11.2
11.4
0.02
220
1712
(3044889) 12 lead EKG panel
2089
19023
1.25
9.00
3.9
3.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1334
11574
1.25
8.82
4.9
5.0
g/l
35.8
35.6
0.71
1234
10776
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
771
6274
1.30
8.64
1.3
1.3
u/ml
2.0
1.7
0.19
223
1628
(3002030) Lymphocytes/100 leukocytes in Blood
1537
13570
1.24
8.61
6.6
6.2
%
28.4
28.3
0.13
1444
12675
(42870588) Differential panel, method unspecified - Blood
1106
9416
1.26
8.57
6.3
6.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1514
13350
1.24
8.57
3.8
3.5
estimate
0.0
0.0
0.50
230
2469
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2744
25884
1.30
8.47
4.0
3.8
mmol/l
1.3
1.3
0.22
2525
23847
(3021601) Nitrite [Presence] in Urine by Test strip
1515
13380
1.24
8.38
5.3
4.7
estimate
0.0
0.0
0.50
245
2544
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2833
26861
1.32
8.26
4.5
4.2
mmol/l
1.5
1.5
0.23
2607
24888
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2851
27056
1.32
8.26
4.5
4.2
mmol/l
4.7
4.7
0.09
2648
25204
(3013512) EKG study
884
7356
1.27
8.25
4.0
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1529
13535
1.23
8.22
3.9
3.5
estimate
0.0
0.0
1.06
238
2457
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
739
6017
1.29
8.20
2.2
1.8
mg/l
1.3
1.2
0.60
576
4546
(3015377) Calcium [Moles/volume] in Serum or Plasma
1061
9035
1.25
8.11
3.1
3.4
mmol/l
2.4
2.4
0.24
905
7956
(3044640) Blood type and Crossmatch panel - Blood
1027
8718
1.25
8.06
2.4
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
684
5527
1.30
8.03
1.7
1.5
g/l
2.5
2.4
0.68
419
3354
(3026493) Urate [Moles/volume] in Serum or Plasma
837
6940
1.27
8.01
2.7
2.7
umol/l
2541.7
4701.9
1.40
720
6079
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
544
4262
1.33
7.99
1.9
1.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
1790
16146
1.23
7.93
8.9
9.2
e9/l
4.0
4.1
0.62
1585
14030
(3048689) Calprotectin [Mass/mass] in Stool
448
3425
1.35
7.74
2.2
2.4
ug/g
102.5
131.9
1.35
341
2716
(3011397) Hemoglobin [Presence] in Urine by Test strip
769
6334
1.28
7.73
3.7
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
947
8030
1.25
7.38
3.2
3.0
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1065
9163
1.24
7.24
3.5
3.3
u/l
30.3
36.1
1.94
997
8709
(3014576) Chloride [Moles/volume] in Serum or Plasma
436
3353
1.34
7.24
9.2
7.0
mmol/l
104.6
104.4
0.27
424
3277
(3015171) Extractable nuclear Ab [Units/volume] in Serum
162
1033
1.60
7.19
1.3
1.2
u/ml
0.3
0.9
1.15
15
84
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1460
12983
1.22
7.17
4.2
4.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
853
7184
1.25
7.01
4.5
4.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
343
2559
1.38
6.91
5.5
4.2
mmol/l
2.0
1.9
0.20
279
2064
(3002385) Erythrocyte distribution width [Ratio]
2498
23499
1.23
6.69
19.0
16.6
%
13.7
13.6
0.14
2453
22980
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1992
18332
1.21
6.63
3.2
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
852
7214
1.24
6.62
7.1
6.8
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
341
2560
1.37
6.61
5.5
4.2
kpa
5.9
5.8
0.65
331
2484
(40768797) Stomach Pathology biopsy report
468
3683
1.31
6.60
1.2
1.2
—
—
—
0
0
(3012544) pH of Venous blood
349
2631
1.36
6.59
5.5
4.2
—
7.4
—
0
13
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
387
2972
1.34
6.47
1.8
1.7
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
788
6654
1.24
6.23
2.4
2.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1361
12152
1.20
6.09
3.0
2.8
ug/l
108.4
118.4
0.76
1270
11291
(3009542) Hematocrit [Volume Fraction] of Blood
2718
25889
1.24
6.01
17.3
14.6
%
39.4
39.9
1.98
1994
19189
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
802
6833
1.23
5.77
2.3
2.3
mg/l
2.9
2.9
0.01
690
5827
(3019150) Specific gravity of Urine by Refractometry
695
5836
1.24
5.74
4.2
3.8
kg/l
1.0
1.0
0.23
96
864
(3018095) Leukocytes [#/volume] in Urine
1104
9717
1.20
5.68
4.0
3.7
e6/l
134.3
98.5
0.39
777
6821
(3030467) Casts [#/volume] in Urine by Automated count
881
7596
1.22
5.62
3.4
3.1
e6/l
0.4
0.4
0.55
665
5716
(3003338) MCHC [Mass/volume]
2548
24162
1.21
5.60
20.2
17.3
g/l
332.4
332.5
0.15
2526
23976
(40768804) Tissue Pathology biopsy report
1243
11074
1.19
5.56
2.2
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
281
2105
1.36
5.54
5.8
3.5
kpa
4.4
4.6
1.48
271
2036
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
172
1182
1.48
5.50
5.4
2.8
%
0.7
0.7
0.09
164
1138
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
565
4664
1.25
5.42
2.9
2.7
e6/l
1.3
1.1
0.47
328
2624
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
175
1211
1.47
5.41
5.4
2.9
%
1.2
1.3
0.12
175
1202
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
376
2956
1.31
5.34
1.8
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
631
5291
1.24
5.24
1.7
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
96
589
1.65
5.08
4.0
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
961
8428
1.19
5.03
3.2
3.2
mmol/l
7.3
7.6
1.14
797
7152
(3012095) Magnesium [Moles/volume] in Serum or Plasma
533
4410
1.25
4.99
3.8
3.6
mmol/l
0.8
0.8
0.32
495
4126
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
189
1349
1.42
4.98
2.5
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
941
8254
1.19
4.89
3.5
3.2
e6/l
33.2
78.0
3.72
733
6322
(3027273) Bicarbonate [Moles/volume] in Venous blood
173
1221
1.44
4.86
4.2
3.4
mmol/l
25.4
25.3
0.10
166
1181
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
618
5214
1.23
4.82
3.9
3.6
ng/l
377.0
634.4
0.54
480
3949
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
396
3177
1.28
4.81
7.5
6.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1373
12457
1.17
4.74
9.8
9.3
e9/l
0.0
0.0
0.66
1120
10129
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
210
1543
1.38
4.70
1.6
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
157
1098
1.45
4.64
2.1
1.5
u/ml
11.9
18.4
—
8
31
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
125
839
1.51
4.54
2.2
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
387
3121
1.27
4.51
4.4
4.3
%
32.2
32.4
0.11
263
2102
(3022948) Iron [Moles/volume] in Serum or Plasma
501
4168
1.24
4.45
2.6
2.5
umol/l
13.4
13.3
0.23
466
3871
(3018677) aPTT in Platelet poor plasma by Coagulation assay
498
4141
1.24
4.45
2.7
2.3
s
29.7
29.8
0.09
486
4024
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
393
3183
1.27
4.42
3.0
2.8
umol/l
6.8
8.0
0.66
337
2762
(3026782) Osmolality of Urine
623
5304
1.21
4.42
3.0
2.7
mosm/kgh2o
553.9
551.0
0.10
525
4516
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
45
230
1.97
4.39
1.4
1.4
mmol/l
12.3
12.5
—
10
54
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
244
1857
1.34
4.38
2.5
2.3
au/ml
25.8
23.7
—
9
115
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
148
1037
1.45
4.35
3.6
5.6
%
1.6
1.6
0.22
138
962
(3016502) Oxygen saturation in Arterial blood
340
2712
1.28
4.34
8.1
7.9
%
95.7
95.7
0.02
325
2612
(3019225) pH of Specimen
323
2561
1.29
4.32
4.2
4.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
299
2347
1.30
4.32
10.2
8.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
821
7196
1.19
4.22
1.7
1.6
mmol/l
1.4
1.4
0.23
692
6109
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
223
1689
1.34
4.15
1.3
1.3
au/ml
26.3
45.5
—
10
69
(3038515) Glucose [Moles/volume] in Venous blood
82
511
1.62
4.15
3.4
3.2
mmol/l
7.6
7.4
0.16
82
497
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
433
3573
1.24
4.15
2.7
2.6
%
22.5
23.0
0.31
365
3080
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1135
10237
1.16
4.07
4.1
3.6
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
86
545
1.59
4.07
3.3
3.1
mmol/l
1.6
1.5
0.20
86
527
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
881
7790
1.18
4.06
4.9
4.7
ug/l
2.6
2.8
0.20
786
6984
(3004789) Transferrin [Mass/volume] in Serum or Plasma
460
3830
1.23
4.05
2.6
2.5
g/l
2.4
2.3
0.47
421
3545
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
638
5488
1.20
4.04
1.7
1.7
pmol/l
37454300.8
25600950.1
0.22
542
4621
(3027945) Reticulocytes/100 erythrocytes in Blood
363
2945
1.26
4.04
3.1
2.8
%
1.8
1.8
0.23
325
2627
(36304419) Bacteria [Presence] in Urine
844
7444
1.18
4.01
3.3
3.0
—
—
—
0
0
(4010399)
239
1840
1.32
3.99
1.6
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
286
2258
1.29
3.97
1.1
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
113
768
1.49
3.92
3.6
3.3
ratio
1.4
2.3
0.51
15
58
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
204
1542
1.34
3.87
1.6
1.6
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
144
1029
1.42
3.85
3.6
5.7
%
0.9
0.9
0.26
133
958
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
65
391
1.68
3.80
1.4
1.4
u/l
32.8
25.1
1.03
51
328
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
190
1426
1.35
3.78
6.2
4.7
mmol/l
24.3
24.1
0.42
165
1304
(4024509)
45
244
1.86
3.74
1.6
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
115
793
1.47
3.72
4.0
3.4
mg/l
75.8
129.6
0.31
101
643
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
115
794
1.46
3.70
4.0
3.4
mg/l
29.3
62.1
1.26
102
644
(3026389) Candida sp identified in Specimen by Organism specific culture
57
334
1.72
3.68
1.7
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
274
2176
1.28
3.65
2.8
2.7
e9/l
71.8
70.4
0.18
206
1615
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
363
2981
1.24
3.64
4.8
4.3
u/l
232.7
247.5
1.70
342
2820
(3036481) Cortisol [Moles/volume] in Serum or Plasma
315
2549
1.26
3.60
2.4
2.2
nmol/l
353.1
373.6
1.23
295
2338
(3000850) Epithelial cells [#/volume] in Urine
655
5706
1.18
3.58
2.7
2.6
e6/l
5.4
6.2
0.61
565
5004
(3051611) Lipemic interference index of Serum or Plasma
48
271
1.78
3.53
3.9
3.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
368
3040
1.24
3.50
7.9
7.5
mmol/l
1.4
1.1
0.49
296
2384
(3017446) Testosterone [Moles/volume] in Serum or Plasma
244
1920
1.29
3.50
2.4
2.2
nmol/l
13.1
12.6
0.38
211
1690
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
98
667
1.48
3.42
1.5
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
309
2511
1.25
3.42
8.4
8.2
g/l
121.7
122.1
0.14
295
2419
(3027801) Oxygen [Partial pressure] in Arterial blood
368
3049
1.23
3.41
7.8
7.5
kpa
12.9
12.5
0.64
352
2904
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
511
4380
1.20
3.35
3.1
2.9
e6/l
2.7
2.6
0.04
276
2353
(1761482) Bacteria [#/volume] in Urine by Culture
92
622
1.49
3.32
5.0
4.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
367
3049
1.23
3.32
7.9
7.5
kpa
5.1
5.1
0.15
351
2903
(3033705) Calcium.ionized [Moles/volume] in Venous blood
51
299
1.72
3.32
2.4
2.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
59
360
1.65
3.31
2.5
2.3
umol/l
6.3
4.9
0.38
44
259
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
39
211
1.86
3.30
2.8
2.3
%
16.9
11.8
1.42
20
101
(3004588) Protein electrophoresis panel - Serum or Plasma
221
1738
1.29
3.21
3.1
2.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
157
1183
1.34
3.10
1.1
1.1
u/ml
16.1
1.3
—
5
16
(1175426) CD3 cells/100 lymphocytes in Blood
39
216
1.81
3.09
2.8
2.3
%
69.8
72.6
0.46
39
204
(3003327) Ova and parasites identified in Stool by Light microscopy
126
918
1.39
3.08
1.6
1.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
396
3343
1.21
3.06
24.5
23.2
inr
1.4
1.3
0.27
45
494
(3011288) Drugs identified in Urine by Screen method
113
810
1.41
3.04
1.9
2.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
46
270
1.71
3.01
2.6
2.5
e9/l
1.0
1.1
0.41
33
168
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
270
2195
1.25
3.00
3.1
2.8
ng/l
149.2
200.7
2.45
245
1986
(3017732) Neutrophils [#/volume] in Blood
238
1909
1.27
2.97
2.8
3.0
e9/l
3.9
4.1
0.76
181
1535
(3052851) Hemolysis interference index of Serum or Plasma
114
822
1.40
2.97
3.4
3.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
199
1562
1.29
2.95
1.3
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
114
2.11
2.94
2.1
2.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
237
1903
1.26
2.94
1.7
1.7
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
258
2094
1.25
2.92
3.8
2.7
g/l
10.6
10.5
0.16
238
1910
(3005322) IgE [Units/volume] in Serum or Plasma
219
1744
1.27
2.91
1.4
1.3
u/ml
156.8
212.9
0.98
201
1610
(40768443) Skin Pathology biopsy report
147
1109
1.34
2.90
1.1
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
892
8072
1.14
2.90
4.1
4.0
mg/mmol
9.1
8.8
0.06
542
5143
(3003458) Phosphate [Moles/volume] in Serum or Plasma
422
3614
1.19
2.81
6.3
6.2
mmol/l
1.0
1.1
0.47
395
3362
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
18
4.45
2.79
1.4
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
57
362
1.58
2.78
1.2
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
266
2182
1.24
2.75
2.3
2.3
ug/l
6.0
7.2
1.03
221
1928
(3028026) IgM [Mass/volume] in Serum or Plasma
205
1633
1.27
2.73
2.5
1.8
g/l
1.3
1.3
0.06
188
1485
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
192
1519
1.28
2.71
1.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
37
211
1.76
2.70
2.9
2.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
38
219
1.74
2.68
8.6
3.7
%
10.1
11.3
0.84
38
219
(3022145) Colonoscopy Study observation
344
2906
1.20
2.66
1.3
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
203
1622
1.27
2.65
5.6
7.2
mmol/l
24.9
24.6
0.43
186
1505
(3028707) Methadone [Presence] in Urine by Screen method
78
537
1.46
2.65
1.9
2.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
84
587
1.44
2.64
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
84
587
1.44
2.64
1.5
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
132
1000
1.33
2.57
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
519
4557
1.16
2.56
1.5
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
287
2393
1.22
2.55
10.3
7.1
mmol/l
1.3
1.3
0.21
277
2301
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
549
4844
1.16
2.54
2.9
3.0
mmol/l
2.5
2.5
0.13
469
4243
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
15
62
2.43
2.53
1.2
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
119
890
1.35
2.53
2.4
1.6
titre
83.3
395.9
—
6
39
(3017315) Amylase [Enzymatic activity/volume] in Urine
26
136
1.92
2.50
1.3
1.3
u/l
161.6
336.9
1.25
26
125
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
21
3.82
2.46
1.5
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
113
1496
0.75
2.43
1.6
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
103
759
1.37
2.42
1.5
1.7
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
107
794
1.36
2.41
1.4
1.4
ug/g
287.5
277.8
0.16
61
453
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
7
17
4.12
2.36
1.3
1.3
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
213
1739
1.24
2.34
10.8
7.7
mmol/l
24.9
24.9
0.02
208
1732
(3000475) Leukocytes [#/volume] in Synovial fluid
86
619
1.40
2.33
1.9
1.6
e6/l
14553.3
12660.7
0.15
64
447
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
394
3413
1.17
2.32
2.0
2.2
—
—
—
0
0
(4133840)
15
65
2.31
2.31
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
122
931
1.32
2.29
1.6
2.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
107
804
1.34
2.24
1.5
1.5
u/l
9.7
10.0
0.07
86
643
(3020630) Protein [Mass/volume] in Serum or Plasma
256
2141
1.21
2.24
3.4
2.6
g/l
67.0
66.5
0.45
234
1960
(3000330) Specific gravity of Urine by Test strip
167
1334
1.26
2.23
4.3
3.1
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
9
5.56
2.21
4.8
7.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
140
1096
1.29
2.20
1.7
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
71
501
1.43
2.17
1.9
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
357
3085
1.18
2.17
2.0
2.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
67
2.24
2.17
1.2
1.1
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
146
1154
1.28
2.14
1.8
1.9
u/l
39.5
39.1
0.09
130
1031
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
103
776
1.34
2.14
1.5
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
23
123
1.88
2.11
2.4
2.0
umol/l
31.6
27.9
0.59
23
117
(3012516) Albumin [Mass/volume] in Urine
838
7691
1.12
2.11
3.4
3.3
mg/l
131.2
300.0
1.20
518
4918
(3013139) Helicobacter pylori Ag [Presence] in Stool
220
1825
1.22
2.10
1.3
1.2
—
—
—
0
0
(3020891) Body temperature
131
1024
1.29
2.10
6.3
4.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
35
214
1.64
2.06
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
42
269
1.57
2.06
2.0
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
178
1448
1.24
2.05
10.3
10.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
67
474
1.42
2.04
1.5
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
241
2024
1.21
2.04
4.2
4.1
ng/l
83.1
87.9
0.34
213
1767
(3020779) Urea [Moles/volume] in Serum or Plasma
287
2453
1.19
2.01
8.3
7.8
mmol/l
9.5
9.5
0.07
273
2348
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
127
996
1.29
2.00
2.0
2.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
127
996
1.29
2.00
2.0
2.3
g/l
3.8
3.8
0.05
86
738
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
127
997
1.28
1.98
2.0
2.3
g/l
7.5
7.4
0.21
93
776
(21494434) Karyotype in Bone marrow
37
233
1.59
1.96
1.3
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
102
779
1.32
1.95
3.8
4.3
mmol/l
3.9
3.9
0.04
90
724
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
5
11
4.55
1.94
6.2
16.5
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
5
11
4.55
1.94
1.2
1.7
ng/l
158.4
200.6
—
5
11
(3027008) Opiates [Presence] in Urine
147
1179
1.26
1.94
1.7
2.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
16
3.75
1.93
5.3
4.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
16
3.75
1.93
5.3
4.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
60
423
1.43
1.89
1.7
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
205
1710
1.21
1.88
3.9
5.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
147
1184
1.25
1.88
1.7
2.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
28
166
1.69
1.87
5.0
3.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
98
750
1.32
1.86
1.3
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
33
205
1.62
1.85
1.4
1.8
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
119
936
1.28
1.85
2.1
2.3
g/l
9.9
10.3
0.48
101
804
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
13
59
2.21
1.84
2.5
1.6
ug/l
0.3
0.4
—
8
35
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
112
875
1.29
1.84
3.1
2.3
g/l
1.4
0.9
0.41
96
769
(3039000) Anion gap in Blood
79
587
1.35
1.84
4.1
7.6
mmol/l
11.0
11.1
0.08
69
520
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
6
17
3.53
1.83
1.0
1.0
u/ml
0.3
8.6
—
6
11
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
208
1743
1.21
1.83
3.5
3.3
pmol/l
4.5
4.5
0.10
187
1552
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
34
214
1.59
1.82
1.1
1.2
—
242.9
—
0
7
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
34
214
1.59
1.82
1.1
1.2
titre
60.0
176.7
—
6
45
(3018572) Chloride [Moles/volume] in Blood
79
588
1.35
1.82
4.1
7.6
mmol/l
104.6
105.3
0.65
69
521
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
174
1434
1.22
1.81
12.1
9.5
mmol/l
24.3
24.3
0.08
160
1350
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
20
108
1.86
1.81
3.8
2.7
%
28.3
29.3
0.11
20
101
(4062490)
40
262
1.53
1.81
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
100
773
1.30
1.78
1.2
1.3
titre
101.3
92.2
—
8
65
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
14
67
2.09
1.75
1.4
1.2
—
—
—
0
0
(3000492) Spirometry study
302
2625
1.17
1.75
1.4
1.4
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
144
1168
1.24
1.75
1.7
1.8
g/l
1.6
1.5
0.54
130
1020
(3024891) Influenza virus A+B Ag [Presence] in Specimen
99
769
1.30
1.72
1.3
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
389
3453
1.14
1.70
1.8
1.8
%
1.4
1.5
0.17
337
3035
(3044290) Cell count panel - Cerebral spinal fluid
78
587
1.34
1.69
2.0
1.6
—
—
—
0
0
(4268621)
17
306
0.55
1.68
2.6
2.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
42
2.38
1.67
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
66
485
1.37
1.67
1.0
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
108
853
1.27
1.66
3.4
3.1
g/l
3.8
3.6
0.83
103
806
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
132
1068
1.25
1.65
1.9
2.0
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
104
818
1.28
1.65
2.8
2.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
104
819
1.28
1.64
3.8
6.6
mmol/l
1.3
1.2
0.13
89
712
(3024139) IgG subclass 3 [Mass/volume] in Serum
39
261
1.50
1.63
1.3
1.3
g/l
0.4
0.4
0.04
27
187
(3028192) IgG subclass 2 [Mass/volume] in Serum
39
261
1.50
1.63
1.3
1.3
g/l
3.1
3.0
0.13
27
187
(3027135) IgG subclass 1 [Mass/volume] in Serum
39
261
1.50
1.63
1.3
1.3
g/l
7.5
6.7
0.55
27
186
(21494814) CD8 cells/100 lymphocytes in Specimen
19
105
1.81
1.62
1.7
1.9
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
116
928
1.26
1.61
2.9
3.5
g/l
0.4
0.3
0.44
50
408
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
82
627
1.32
1.61
1.9
1.6
e6/l
209.5
1329.0
1.54
71
505
(3006245) CD3-CD19+ cells/100 cells in Blood
20
113
1.77
1.60
3.7
2.9
%
13.8
10.8
0.46
20
105
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
678
6244
1.11
1.59
4.3
4.1
%
22.7
21.8
0.72
297
2985
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
114
912
1.26
1.59
2.6
2.4
ug/l
385.7
519.3
0.38
105
852
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
115
921
1.26
1.59
1.4
1.3
miu/ml
183.5
224.6
0.70
51
433
(3000764) Benzodiazepines [Presence] in Urine
143
1174
1.23
1.58
1.7
2.0
—
—
—
0
0
(4281824)
16
287
0.56
1.57
1.1
1.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
25
152
1.65
1.56
1.4
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
177
1487
1.20
1.56
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
17
92
1.85
1.55
1.8
1.9
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
33
2.43
1.53
1.5
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
48
340
1.42
1.52
1.6
1.5
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
126
1026
1.24
1.51
2.1
2.0
ug/l
1.9
2.2
0.10
108
910
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
133
1090
1.23
1.51
4.3
4.3
mmol/l
25.1
24.8
0.72
126
1015
(3049717) Cytology report of Urine Cyto stain
117
946
1.25
1.50
2.9
2.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
58
426
1.37
1.50
1.7
1.2
u/l
103.5
45.9
0.75
49
368
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
81
626
1.30
1.49
1.9
1.6
e6/l
53.6
32.0
0.31
65
479
(3027944) Amphetamines [Presence] in Urine
140
1156
1.22
1.48
1.7
1.9
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
37
2.44
1.47
1.4
1.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
246
2139
1.16
1.46
3.8
3.4
—
—
—
0
0
(3002256) Pathology report gross observation
395
3549
1.13
1.45
1.3
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
9
38
2.37
1.45
2.1
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
20
117
1.71
1.44
3.6
3.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
223
1926
1.17
1.44
1.2
1.2
iu/ml
166.5
150.2
0.21
88
718
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
52
2.12
1.44
5.6
5.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
376
3370
1.13
1.44
1.7
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
75
577
1.31
1.44
1.2
1.2
u/ml
10.8
41.3
3.69
12
59
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
116
943
1.24
1.43
2.1
2.3
g/l
3.1
3.1
0.02
90
757
(3010503) CD19 cells [#/volume] in Blood
26
164
1.59
1.43
1.7
2.3
e9/l
0.2
0.2
0.02
26
158
(3022313) Gas panel - Capillary blood
150
1253
1.21
1.42
3.9
4.1
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
19
110
1.73
1.42
1.7
1.9
%
8.7
8.5
0.01
19
105
(21494815) CD4 cells/100 lymphocytes in Specimen
35
237
1.48
1.41
2.9
2.3
%
55.2
45.3
—
5
24
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
9
40
2.25
1.40
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
101
813
1.25
1.37
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
43
306
1.41
1.36
1.8
1.6
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
17
2.94
1.36
12.4
6.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
63
478
1.32
1.35
1.6
1.7
—
—
—
0
0
(4034850)
107
869
1.24
1.35
13.2
9.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
38
265
1.44
1.34
4.6
3.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
40
282
1.42
1.33
1.3
1.6
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
89
710
1.26
1.31
1.4
1.2
u/ml
1.4
8.1
0.83
11
67
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
80
630
1.28
1.31
1.6
1.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
101
818
1.24
1.31
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
39
275
1.42
1.30
1.6
1.4
mosm/kgh2o
282.0
281.3
0.08
34
209
(3029937) Albumin [Presence] in Urine by Test strip
764
7145
1.09
1.30
4.3
3.8
estimate
0.0
0.0
1.34
240
2454
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
96
774
1.25
1.30
1.4
1.2
u/ml
40.2
44.4
—
7
47
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
43
309
1.40
1.30
1.3
1.6
—
—
—
0
0
(4211845)
21
129
1.63
1.29
3.4
2.9
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
14
76
1.85
1.29
1.1
1.2
g/l
40.8
38.0
—
7
43
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
96
775
1.25
1.29
2.1
2.2
g/l
0.0
0.0
0.15
88
719
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
245
2153
1.15
1.29
2.9
2.6
ml/min/173m2
66.4
67.4
0.17
92
829
(3033658) Prothrombin time (PT) actual/Normal
761
7120
1.09
1.28
4.6
4.0
%
89.8
90.3
0.23
744
6944
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
22
342
0.64
1.28
1.1
1.0
u/ml
0.5
0.3
—
6
90
(3024928) Oxygen saturation in Venous blood
75
588
1.28
1.28
6.6
3.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
19
114
1.67
1.28
2.6
3.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
776
7269
1.09
1.27
3.5
3.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
73
572
1.28
1.26
6.6
5.7
iu/ml
242.3
632.0
—
10
74
(3035611) Eosinophils/100 leukocytes in Synovial fluid
6
25
2.40
1.24
1.7
1.5
%
0.6
0.4
—
6
15
(3050129) First trimester maternal screen panel - Serum or Plasma
69
878
0.78
1.24
1.6
1.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
8
36
2.23
1.24
1.1
1.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
585
5419
1.10
1.23
1.9
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
101
826
1.23
1.22
1.2
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
89
718
1.25
1.21
1.4
1.2
u/ml
2.4
7.3
1.52
18
110
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
19
2.63
1.21
7.2
5.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
46
339
1.36
1.21
1.6
1.5
—
—
—
0
0
(44813793)
27
180
1.50
1.20
1.1
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
148
1259
1.18
1.19
1.7
1.9
—
—
—
0
0
(44806420)
13
71
1.83
1.19
2.2
2.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
497
4578
1.10
1.19
2.9
3.0
ug/l
0.7
0.8
2.20
308
3022
(3037756) Immunofixation for Serum or Plasma
67
524
1.28
1.18
2.2
1.7
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
26
2.31
1.18
1.5
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
76
604
1.26
1.18
1.6
1.3
u/ml
256.9
255.7
0.01
55
365
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
43
315
1.37
1.18
1.3
1.5
%
67.9
59.8
0.70
23
201
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
26
173
1.51
1.17
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
22
141
1.56
1.17
2.5
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
43
316
1.37
1.16
1.2
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
122
1023
1.20
1.16
2.0
1.8
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
20
2.50
1.15
1.2
1.0
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
185
0.54
1.15
21.5
18.1
nmol/l
1785.2
1510.8
—
10
180
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
125
1052
1.20
1.15
1.6
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
71
563
1.27
1.14
4.0
3.8
%
56.5
56.7
0.03
71
563
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
92
752
1.23
1.13
1.7
1.8
nmol/l
45.2
39.5
1.22
87
729
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
43
318
1.36
1.13
1.2
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
116
973
1.20
1.11
1.9
1.8
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
20
127
1.58
1.11
5.1
3.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
15
88
1.71
1.11
1.2
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
97
800
1.22
1.10
1.9
2.1
g/l
37.6
37.9
0.24
83
700
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
30
209
1.44
1.10
1.4
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
10
182
0.55
1.10
13.5
13.0
nmol/l
963.4
851.9
—
10
174
(3050794) Legionella sp Ab [Presence] in Serum
5
21
2.38
1.09
1.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
54
416
1.30
1.09
2.4
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
81
1.73
1.09
2.4
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
14
81
1.73
1.09
2.4
2.8
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
41
1.95
1.08
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
117
1384
0.84
1.08
1.4
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
336
3050
1.11
1.08
1.8
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
45
592
0.76
1.07
1.4
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
36
261
1.38
1.07
1.5
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
74
1.76
1.06
5.7
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
40
296
1.36
1.06
2.1
2.3
mg/l
29.0
23.2
—
10
73
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
33
2.12
1.05
7.4
10.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
18
113
1.60
1.05
1.4
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
18
113
1.60
1.05
1.4
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
18
113
1.60
1.05
1.4
1.9
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
21
137
1.54
1.05
1.6
1.6
—
9.5
—
0
7
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
39
288
1.36
1.05
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
70
561
1.25
1.05
1.4
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
42
314
1.34
1.04
1.2
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
32
229
1.40
1.03
2.7
2.8
mg/l
25.9
38.0
0.31
23
162
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
84
691
1.22
1.00
1.3
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
9
48
1.88
1.00
1.8
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
19
123
1.55
0.99
2.8
2.0
umol/l
2.3
1.9
0.81
19
117
(3023323) Follitropin [Units/volume] in Serum or Plasma
147
1274
1.16
0.99
1.4
1.4
iu/l
30.8
28.5
0.32
124
1057
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
49
1.84
0.98
1.0
1.1
%
104.7
89.9
—
9
49
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
49
1.84
0.98
1.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
23
2.18
0.98
1.4
1.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
23
2.18
0.98
1.4
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
22
148
1.49
0.97
1.6
1.3
nmol/l
134.1
135.3
0.06
22
148
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
108
914
1.19
0.97
3.5
2.8
%
88.2
91.7
0.95
99
858
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
100
1.60
0.96
1.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
41
310
1.33
0.96
1.2
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
41
310
1.33
0.96
1.2
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
9
50
1.80
0.96
1.1
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
9
50
1.80
0.96
3.1
2.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
9
50
1.80
0.96
1.1
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
9
50
1.80
0.96
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
22
149
1.48
0.95
2.0
2.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
41
311
1.32
0.95
1.2
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
20
133
1.51
0.94
1.8
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
49
623
0.78
0.93
1.6
1.7
—
—
—
0
0
(3001729) Color of Synovial fluid
6
27
2.22
0.93
1.7
1.5
—
—
—
0
0
(4015189)
9
52
1.73
0.92
1.4
2.8
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
45
577
0.78
0.92
1.3
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
37
487
0.76
0.92
1.0
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
53
419
1.27
0.91
1.3
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
28
2.14
0.91
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
28
2.14
0.91
1.3
1.0
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
98
828
1.19
0.91
3.7
3.0
%
185.5
187.2
0.07
93
789
(3005033) Fetal Nuchal fold Thickness US
45
575
0.78
0.90
1.3
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
71
582
1.22
0.90
3.6
3.4
mg/l
28.6
27.5
0.08
44
359
(1617658) Protocol used for examination of sentinel lymph nodes
14
219
0.64
0.90
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
367
1.28
0.89
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
54
432
1.25
0.86
2.1
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
74
613
1.21
0.86
1.8
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
39
299
1.31
0.86
2.9
2.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
22
153
1.44
0.85
2.2
2.6
%
36.3
41.0
0.46
12
48
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
52
415
1.26
0.85
1.1
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
72
596
1.21
0.84
1.8
1.6
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
31
1.94
0.84
1.2
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
31
1.94
0.84
1.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
15
96
1.56
0.84
1.0
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
43
336
1.28
0.83
1.3
1.4
pmol/l
304.4
285.7
0.12
33
263
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
69
570
1.21
0.83
1.3
1.2
u/ml
1.0
4.0
—
5
43
(3038026) Centromere Ab [Units/volume] in Serum
29
214
1.36
0.82
1.3
1.2
—
46.2
—
0
13
(3029634) Reagin Ab [Titer] in Serum by VDRL
49
390
1.26
0.82
2.5
2.0
—
3.7
—
0
8
(3011841) English Walnut IgE Ab [Units/volume] in Serum
6
32
1.88
0.81
1.2
1.0
u/ml
23.8
1.4
—
6
22
(3000285) Sodium [Moles/volume] in Blood
6
32
1.88
0.81
1.0
1.1
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
6
32
1.88
0.81
1.2
1.0
u/ml
14.5
0.8
—
6
20
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
318
0.72
0.81
1.4
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
942
9817
0.94
0.80
3.0
2.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
64
772
0.83
0.79
1.4
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
83
702
1.19
0.79
1.9
1.9
iu/l
2.7
5.1
3.73
34
252
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
85
721
1.18
0.78
2.1
2.2
g/l
0.0
0.0
0.00
77
673
(3023183) Ammonium ion [Moles/volume] in Plasma
68
565
1.21
0.78
3.3
2.9
umol/l
34.7
36.2
0.14
63
483
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
15
98
1.53
0.78
1.1
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
90
1.56
0.78
3.9
2.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
42
331
1.27
0.77
2.6
2.4
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
32
243
1.32
0.77
1.4
1.4
e6/l
137611.9
59373.7
0.26
16
164
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
47
376
1.25
0.77
1.3
1.3
mmol/l
7.8
7.1
0.56
32
271
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
35
450
0.78
0.76
1.2
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
20
140
1.43
0.76
2.1
1.6
umol/l
28.9
25.6
0.17
20
130
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
67
558
1.20
0.76
1.9
1.4
u/ml
109.8
116.0
0.19
14
100
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
18
124
1.45
0.75
1.0
1.0
—
—
—
0
0
(4027681)
24
175
1.37
0.74
1.3
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
191
1726
1.11
0.73
4.4
4.0
kpa
5.2
5.2
0.06
178
1603
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
26
193
1.35
0.73
1.1
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
34
263
1.30
0.73
1.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
18
125
1.44
0.72
1.6
2.0
ug/l
27.1
268.1
0.66
18
113
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
92
1.52
0.72
1.1
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
20
142
1.41
0.72
1.4
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
20
142
1.41
0.72
1.4
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
20
142
1.41
0.72
1.4
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
20
142
1.41
0.72
1.4
1.7
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
85
728
1.17
0.72
2.1
2.2
g/l
0.0
0.0
0.00
77
674
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
175
1576
1.12
0.72
1.9
1.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
84
1.55
0.71
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
12
76
1.58
0.71
1.1
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
183
1653
1.11
0.71
4.4
3.9
mmol/l
1.8
1.8
0.09
147
1234
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
7
40
1.75
0.71
1.3
1.2
nmol/l
5.2
4.9
—
7
40
(3024980) IgG subclass 4 [Mass/volume] in Serum
53
435
1.22
0.71
1.4
1.6
g/l
1.0
0.8
0.21
41
340
(3044009) aPTT.lupus sensitive (LA screen)
5
26
1.92
0.70
1.2
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
475
4479
1.07
0.70
1.6
1.6
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
214
2343
0.91
0.70
3.8
3.7
—
—
—
0
0
(3036489) Thrombin time
122
1078
1.14
0.69
3.2
2.5
s
20.9
21.5
0.91
109
947
(3009343) pH of Capillary blood
188
1705
1.11
0.69
4.4
4.0
ph
7.4
7.4
0.02
16
199
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
85
1.53
0.69
1.0
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
196
1782
1.11
0.68
3.4
2.8
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
10
61
1.64
0.68
1.6
3.0
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
59
703
0.84
0.67
1.4
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
292
2708
1.09
0.67
2.6
2.4
u/l
35.0
56.5
0.63
251
2321
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
77
659
1.17
0.67
1.6
1.6
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
5
92
0.54
0.67
1.2
2.3
e6/l
1669.2
792.1
—
5
68
(3024869) Neuronal Ab [Presence] in Serum
7
43
1.63
0.66
1.3
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
59
701
0.84
0.65
1.4
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
57
476
1.20
0.65
1.4
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
250
2707
0.92
0.65
1.3
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
49
403
1.22
0.65
4.9
5.3
umol/l
381.7
366.9
0.30
42
347
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
7
44
1.59
0.65
1.0
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
39
313
1.25
0.65
1.2
1.2
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
25
189
1.33
0.64
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
116
1028
1.13
0.64
1.9
1.6
mu/l
316.8
298.5
0.27
107
926
(3025130) Human papilloma virus identified in Specimen
46
377
1.22
0.64
1.6
1.8
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
87
756
1.15
0.63
1.4
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
43
350
1.23
0.63
1.3
1.5
mu/l
23.2
53.8
2.58
38
316
(3004616) Nuclear Ab [Presence] in Serum
41
332
1.24
0.63
1.6
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
23
172
1.34
0.63
1.1
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
50
414
1.21
0.63
1.2
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
279
1.26
0.62
5.2
4.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
23
173
1.33
0.61
1.7
1.5
u/ml
21.0
22.2
—
7
33
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
8
50
1.60
0.61
5.1
3.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
60
705
0.85
0.60
1.4
1.4
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
37
455
0.81
0.60
1.3
1.3
u/ml
5.9
4.4
0.13
14
157
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
214
1971
1.09
0.59
2.0
2.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
80
1.50
0.59
1.2
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
60
704
0.85
0.59
1.4
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
54
454
1.19
0.59
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
34
272
1.25
0.59
1.1
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
381
1.21
0.59
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
25
192
1.30
0.59
2.0
2.5
e6/l
780.5
680.4
—
10
73
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
25
192
1.30
0.59
1.0
1.1
iu/ml
7.2
10.8
—
5
48
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
11
72
1.53
0.59
1.5
1.3
%
36.8
29.3
—
6
50
(3008536) Aspergillus sp Ab [Presence] in Serum
8
53
1.51
0.58
1.5
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
830
8004
1.05
0.58
1.4
1.5
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
13
89
1.46
0.58
4.5
2.8
e6/l
152.5
170.2
—
8
50
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
13
89
1.46
0.58
1.2
1.1
%
100.6
89.5
—
5
45
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
8
54
1.48
0.57
4.8
5.5
%
62.0
74.0
—
8
43
(3021879) Hepatitis B virus core Ab [Presence] in Serum
237
2198
1.08
0.57
1.6
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
81
1.48
0.57
1.3
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
98
1.43
0.56
1.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
20
150
1.34
0.55
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
38
311
1.22
0.55
1.2
1.3
nmol/l
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
90
1.45
0.55
1.9
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
29
230
1.26
0.55
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
29
230
1.26
0.55
1.3
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
29
230
1.26
0.55
1.3
1.6
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
16
217
0.74
0.55
1.3
1.3
mmol/l
2.2
2.1
0.13
16
208
(40760892) CBC W Ordered Manual Differential panel - Blood
647
6213
1.05
0.54
5.2
4.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
6
38
1.58
0.54
1.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
142
1.34
0.54
1.3
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
54
459
1.18
0.54
1.2
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
99
1.42
0.54
1.1
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
29
231
1.26
0.53
1.6
1.5
%
31.5
34.7
0.16
13
140
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
61
1.48
0.53
1.3
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
236
2533
0.93
0.53
1.6
1.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
39
1.54
0.53
1.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
23
178
1.29
0.53
1.2
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
36
295
1.22
0.52
6.4
5.3
mmol/l
7.4
7.5
0.07
31
251
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
99
883
1.12
0.52
1.5
1.6
iu/ml
0.3
7.8
0.57
24
176
(3023419) Bacteria identified in Sputum by Culture
42
350
1.20
0.52
3.5
2.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
120
1083
1.11
0.52
1.4
1.7
mg/l
3.3
3.9
0.40
85
760
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
45
378
1.19
0.52
1.7
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
120
1084
1.11
0.51
1.8
2.3
u/l
4404.8
4123.2
0.06
38
430
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
40
333
1.20
0.51
1.2
1.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
26
206
1.26
0.51
1.8
1.6
mmol/l
8.1
7.5
0.63
15
121
(3048929) Epstein Barr virus Ab [Presence] in Serum
110
991
1.11
0.50
1.5
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
41
1.46
0.50
2.0
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
101
906
1.12
0.50
3.0
3.6
u/ml
0.4
0.3
0.37
62
519
(3048879) Bone marrow aspiration report
10
67
1.49
0.49
2.1
2.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
12
84
1.43
0.49
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
33
271
1.22
0.48
1.3
1.2
u/l
58.3
61.0
0.12
24
191
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
21
163
1.29
0.48
1.0
1.1
u/l
1.0
1.1
—
9
80
(3006922) Hepatitis E virus Ab [Presence] in Serum
25
199
1.26
0.48
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
76
672
1.13
0.47
1.6
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
47
1.49
0.47
1.6
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
102
1.37
0.47
1.1
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
30
245
1.23
0.46
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
37
440
0.84
0.46
1.3
1.3
u/ml
7.1
4.0
0.38
16
193
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
430
1.17
0.46
1.3
1.5
nmol/l
0.3
0.4
0.78
42
333
(40768806) Pleura Pathology biopsy report
21
265
0.79
0.45
1.6
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
33
396
0.83
0.45
1.0
1.1
u/ml
4.1
3.1
0.24
13
180
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
11
77
1.43
0.45
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
174
1.27
0.44
1.3
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
276
2606
1.06
0.44
2.3
2.4
g/l
0.2
0.2
0.57
247
2431
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
139
1.30
0.43
1.3
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
26
211
1.23
0.43
2.3
2.3
—
—
—
0
0
(3019977) pH of Arterial blood
19
148
1.29
0.43
2.5
3.0
ph
7.4
7.4
—
5
53
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
85
764
1.12
0.42
8.5
5.4
mg/l
1.5
1.5
0.29
76
707
(3010375) cycloSPORINE [Mass/volume] in Blood
17
131
1.30
0.42
25.6
26.8
ug/l
100.3
122.4
0.89
12
109
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
70
1.43
0.41
1.2
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
58
1.38
0.41
1.3
1.3
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
5
33
1.52
0.41
1.0
2.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
(4038314)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
26
213
1.22
0.40
1.1
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
16
123
1.30
0.40
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
55
483
1.14
0.40
1.1
1.1
—
—
—
0
0
(4306422)
37
433
0.85
0.40
1.3
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
11
149
0.74
0.40
1.1
1.1
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
12
88
1.36
0.40
1.2
1.3
%
106.0
88.7
—
5
45
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
24
196
1.23
0.39
1.6
1.6
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
232
2192
1.06
0.38
4.2
3.8
mmol/l
1.2
1.2
0.21
201
1905
(3051593) INR in Capillary blood by Coagulation assay
12
89
1.35
0.37
9.0
14.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
47
536
0.88
0.37
1.4
1.5
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
23
188
1.22
0.37
1.3
1.3
u/ml
0.5
1.4
0.64
12
80
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
179
1.23
0.37
1.1
1.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
15
116
1.29
0.37
1.2
1.1
iu/ml
283.3
190.1
0.23
15
116
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
421
1.14
0.36
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
78
0.64
0.35
1.0
1.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
68
612
1.11
0.35
3.3
4.2
mmol/l
2.4
2.7
0.39
39
417
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
42
1.43
0.35
1.3
1.5
ng/l
134.7
116.7
—
6
42
(3006184) Hemoglobin [Mass/volume] in Capillary blood
66
593
1.12
0.35
2.1
2.2
g/l
130.7
129.3
0.14
43
430
(3015183) Erythrocyte sedimentation rate
19
153
1.24
0.35
1.4
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
68
613
1.11
0.34
3.3
4.2
kpa
4.9
5.0
0.68
63
607
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
181
1.22
0.34
1.1
1.2
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
6
44
1.36
0.34
1.2
1.4
nmol/l
9.3
760007.6
—
6
35
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
161
1714
0.94
0.34
1.4
1.4
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
45
1.33
0.33
1.0
1.9
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
6
45
1.33
0.33
4.3
3.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
221
2098
1.06
0.33
4.2
4.1
%
0.0
0.2
0.70
52
494
(3035880) pH of Pleural fluid
10
132
0.76
0.32
1.3
1.4
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
27
229
1.18
0.32
1.2
1.1
mg/l
25.5
44.4
3.88
22
191
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
137
1.24
0.32
1.9
2.6
u/ml
1008.2
1097.6
0.12
17
137
(4198724)
17
137
1.24
0.32
1.7
1.8
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
68
617
1.10
0.32
3.3
4.2
kpa
8.9
8.6
1.10
63
610
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
60
664
0.90
0.31
1.4
1.6
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
18
147
1.23
0.30
2.1
2.0
ug/l
2.1
2.3
0.23
13
127
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
55
1.27
0.30
1.7
2.2
umol/l
19.9
18.0
—
7
55
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
7
55
1.27
0.30
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
20
239
0.84
0.29
1.6
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
102
948
1.08
0.29
1.4
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
335
0.86
0.29
4.2
2.8
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
17
139
1.22
0.29
1.8
2.4
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
57
1.23
0.29
1.1
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
176
1.19
0.28
1.0
1.0
ng/l
844.0
704.5
0.50
11
117
(3014051) Protein [Presence] in Urine by Test strip
72
660
1.09
0.28
1.9
2.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
67
612
1.10
0.28
1.1
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
29
334
0.87
0.28
1.6
1.5
g/l
33.6
32.4
0.22
24
302
(21491868) Cryoglobulin [Mass/volume] in Serum
13
103
1.26
0.28
1.1
1.2
g/l
—
0.1
—
0
9
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
11
140
0.79
0.28
1.4
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
76
1.32
0.28
1.5
2.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
94
1.28
0.28
1.7
1.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
17
205
0.83
0.28
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
8
63
1.27
0.27
1.4
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
35
396
0.88
0.27
1.1
1.1
u/ml
4.0
4.0
0.01
21
153
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
16
131
1.22
0.27
1.0
1.1
miu/ml
1585.6
1546.8
0.05
16
131
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
168
1.19
0.27
1.0
1.1
ratio
1.1
1.0
—
8
62
(40768441) Liver Pathology biopsy report
17
204
0.83
0.27
1.4
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
10
128
0.78
0.26
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
243
2331
1.05
0.26
4.1
4.1
%
0.7
0.8
0.61
63
641
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
21
178
1.18
0.26
1.0
1.0
ng/l
30.9
42.4
1.51
12
117
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
71
0.70
0.26
8.4
5.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
71
0.70
0.26
4.2
2.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
16
132
1.21
0.25
2.1
1.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
22
188
1.17
0.25
1.0
1.0
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
26
226
1.15
0.24
1.4
1.4
promille
1.4
1.3
0.10
20
183
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
23
198
1.16
0.24
1.5
1.4
pmol/l
95.0
212.9
—
9
60
(3001964) Herpes simplex virus Ag [Presence] in Specimen
11
87
1.27
0.24
1.5
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
27
236
1.15
0.24
1.2
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
78
1.28
0.24
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
22
189
1.17
0.24
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
72
776
0.93
0.24
1.8
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
18
152
1.19
0.23
1.9
1.6
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
39
1.28
0.23
1.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
11
88
1.25
0.22
1.1
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
91
0.77
0.22
1.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
15
125
1.20
0.22
1.1
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
79
1.27
0.22
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
33
295
1.12
0.22
2.4
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
29
257
1.13
0.22
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
59
545
1.08
0.22
1.6
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
78
729
1.07
0.22
1.1
1.1
u/ml
2.1
5.3
—
8
95
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
280
2710
1.04
0.21
3.8
4.1
ug/l
8.2
29.3
2.52
222
2187
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
87
926
0.94
0.21
1.3
1.3
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.1
—
8.2
—
0
11
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.3
—
0
11
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
14
0.00
0.20
0.0
2.9
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
13
108
1.20
0.20
1.4
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
13
108
1.20
0.20
1.4
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
49
1.22
0.20
1.8
1.5
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
50
1.20
0.19
1.2
1.5
—
—
—
0
0
(3010421) pH of Blood
78
733
1.07
0.19
3.2
3.9
ph
7.4
7.4
0.55
63
606
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
51
1.18
0.19
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
46
499
0.92
0.19
1.6
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
90
1.22
0.19
1.5
1.7
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
27
241
1.12
0.19
3.0
2.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
220
2127
1.04
0.19
3.4
3.9
%
0.5
0.5
0.06
40
463
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
137
1.17
0.18
1.4
1.6
u/field
1.9
3.1
—
10
102
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
19
217
0.87
0.18
1.5
1.5
g/l
0.8
1.0
2.03
19
217
(3008116) Ketones [Moles/volume] in Urine by Test strip
7
58
1.21
0.18
1.4
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
17
147
1.16
0.18
2.2
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
17
147
1.16
0.18
2.2
2.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
61
1.15
0.17
1.4
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
24
214
1.12
0.17
1.6
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
294
2863
1.03
0.17
1.6
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
18
157
1.15
0.17
1.2
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
10
82
1.22
0.17
1.0
1.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
278
0.90
0.17
1.6
1.4
e6/l
10679.1
60560.9
1.73
14
170
(3010726) Horse dander IgE Ab [Units/volume] in Serum
45
485
0.93
0.17
1.1
1.1
u/ml
0.8
2.5
1.83
16
123
(3021440) Promyelocytes/100 leukocytes in Blood
229
2224
1.03
0.16
4.2
4.1
%
0.1
0.1
0.43
55
598
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
20
177
1.13
0.16
1.0
1.0
ng/l
221.4
298.9
1.52
11
120
(4035726)
249
2424
1.03
0.15
1.4
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
51
477
1.07
0.15
3.0
3.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
100
956
1.05
0.15
1.6
1.5
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
59
555
1.06
0.15
1.5
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
6
80
0.75
0.15
1.2
1.9
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
20
178
1.12
0.15
1.7
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
44
472
0.93
0.15
2.9
3.1
nmol/l
0.8
0.8
0.14
35
363
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
23
255
0.90
0.15
2.3
2.7
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
18
159
1.13
0.15
1.8
1.4
nmol/l
1.8
1.2
—
9
130
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
159
1.13
0.15
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
17
192
0.88
0.14
2.4
1.8
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
7
86
0.81
0.14
3.7
7.2
mmol/l
25.1
24.8
—
7
78
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
586
1.06
0.14
1.3
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
90
0.78
0.14
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
13
112
1.16
0.14
2.5
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
23
208
1.11
0.14
2.0
2.0
u/field
2.7
1.9
—
10
84
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
62
587
1.06
0.14
1.1
1.1
u/ml
1.2
1.8
0.29
29
251
(44806118)
35
324
1.08
0.14
1.6
1.5
—
—
—
0
0
(44790048)
35
324
1.08
0.14
1.6
1.5
—
—
—
0
0
(44790049)
35
324
1.08
0.14
1.6
1.5
—
—
—
0
0
(44790047)
35
324
1.08
0.14
1.6
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
32
295
1.09
0.14
1.6
1.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
98
0.82
0.13
1.0
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
54
571
0.94
0.13
2.2
2.1
nmol/l
0.9
0.8
0.35
47
478
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
12
104
1.15
0.12
1.2
1.2
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
10
85
1.18
0.12
1.1
1.1
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
54
569
0.95
0.12
2.3
2.4
%
16.7
16.3
0.26
24
295
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
45
477
0.94
0.12
1.1
1.1
iu/ml
71.0
1230.2
—
6
110
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
30
278
1.08
0.12
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
64
611
1.05
0.11
2.5
2.4
ug/min
135.2
108.2
0.17
38
384
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
45
426
1.06
0.10
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
15
167
0.90
0.10
1.5
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
13
115
1.13
0.10
1.1
1.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
52
495
1.05
0.10
2.7
2.9
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
65
677
0.96
0.10
4.2
3.4
mmol/l
24.9
25.1
0.15
55
594
(3036071) Salmonella sp Ab [Titer] in Serum
12
106
1.13
0.09
1.1
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
291
2863
1.02
0.09
1.4
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
31
330
0.94
0.09
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
29
309
0.94
0.09
1.6
1.4
e6/l
4441.6
2267.0
0.37
23
224
(3012441) Differential panel - Pleural fluid
25
268
0.93
0.09
1.6
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
6
55
1.09
0.08
1.2
1.1
u/ml
30.4
54.0
—
6
55
(40768793) Breast Pathology biopsy report
61
634
0.96
0.08
1.3
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
37
390
0.95
0.08
1.5
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
51
489
1.04
0.08
1.4
1.6
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
24
224
1.07
0.08
1.3
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
24
224
1.07
0.08
1.3
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
24
224
1.07
0.08
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
42
440
0.95
0.08
3.0
1.4
mmol/l
75.1
63.2
0.72
31
348
(3041806) Other cells [#/volume] in Blood by Manual count
13
117
1.11
0.08
1.8
1.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
67
1.04
0.08
1.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
19
176
1.08
0.07
1.5
1.5
—
—
—
0
0
(4146454)
26
276
0.94
0.07
2.8
2.7
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
76
1.05
0.07
1.3
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
281
2773
1.01
0.07
3.3
3.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
12
108
1.11
0.07
7.0
4.4
—
—
—
0
0
(1002224) Polysomnography panel
111
1135
0.98
0.07
1.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
25
265
0.94
0.07
4.5
3.7
u/ml
64.7
43.3
0.27
25
265
(3024471) HLA-A [Type]
8
92
0.87
0.06
1.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
24
226
1.06
0.06
1.3
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
24
226
1.06
0.06
1.3
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
24
226
1.06
0.06
1.3
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
16
172
0.93
0.06
1.2
1.4
u/l
12.3
13.6
0.37
16
166
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
25
263
0.95
0.05
5.3
4.3
u/ml
151.5
101.2
—
7
66
(1616796) Gas panel - Central venous blood
60
616
0.97
0.05
3.5
3.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
30
313
0.96
0.05
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
140
0.93
0.04
1.4
2.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
41
423
0.97
0.04
1.5
1.3
—
—
—
0
0
(4094501)
73
715
1.02
0.04
1.1
1.1
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
15
160
0.94
0.04
8.3
6.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
37
358
1.03
0.04
1.1
1.1
u/ml
1.9
4.4
1.53
25
154
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
109
0.92
0.04
3.3
2.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
44
428
1.03
0.03
3.6
3.6
%
2.7
1.3
0.77
38
328
(3002523) Influenza virus A Ag [Presence] in Specimen
48
468
1.03
0.03
1.0
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
73
717
1.02
0.03
4.5
3.9
kpa
8.6
8.5
0.23
67
670
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
171
1.05
0.03
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
26
251
1.04
0.02
1.7
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
152
1.05
0.02
1.9
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
97
959
1.01
0.02
3.3
3.4
u/ml
104.2
5355.2
1.09
80
812
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
36
368
0.98
0.01
1.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
153
1.05
0.01
1.9
1.5
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
18
173
1.04
0.01
1.1
1.1
nmol/l
7.3
5.6
—
5
33
(3004775) Volume in Urine collected for unspecified duration
21
203
1.03
0.01
2.9
2.3
ml
611.9
654.2
0.27
15
141
(3000012) Reticulocyte production index
13
128
1.02
0.00
1.8
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
13
135
0.96
0.00
1.1
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
47
468
1.00
0.00
1.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
53
525
1.01
0.00
1.1
1.1
u/ml
4.8
5.5
0.20
32
283
(3045683) HLA typing for celiac disease panel - Blood or Tissue
18
181
0.99
0.00
1.1
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
24
241
1.00
0.00
1.3
1.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
54
541
1.00
0.00
2.8
3.5
u/ml
1537.7
821.4
0.19
49
504
(3008401) Mugwort IgE Ab [Units/volume] in Serum
51
507
1.01
0.00
1.1
1.1
u/ml
0.2
1.5
2.60
22
230
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
157
1.02
0.00
2.1
1.8
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
7
69
1.01
0.00
1.3
1.5
g/l
14.4
13.0
—
7
50
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
53
0.94
0.00
1.2
1.5
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
85
0.94
0.00
1.1
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
55
0.91
0.00
1.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.5
—
1642.8
—
0
6
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
5
59
0.85
0.00
1.4
1.3
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
59
1.02
0.00
10.2
8.4
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
125.3
—
0
5
(3042301) Urate [Moles/volume] in Synovial fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
268.0
—
0
5
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
7
72
0.97
0.00
1.6
1.4
ug/l
8.0
8.7
—
7
72
(3049242) von Willebrand panel - Platelet poor plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
67
0.90
0.00
10.2
8.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
5
54
0.93
0.00
2.0
2.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
66
0.91
0.00
1.0
1.2
—
—
—
0
0
(3032333) Phosphate [Mass or Moles] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid
0
5
0.00
0.00
0.0
3.8
—
1.0
—
0
5
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
6
60
1.00
0.00
1.2
1.4
%
91.7
105.0
—
6
55
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
9
91
0.99
0.00
5.6
4.8
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
54
0.93
0.00
1.2
3.1
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_HL_CON_NAS and mortality.

Females

Parameter HR [95% CI] p-value
H8_HL_CON_NAS 0.969 [0.88, 1.07] 0.529
Birth year 0.997 [0.99, 1.01] 0.503

During the follow-up period (1.1.1998 — 31.12.2019), 1734 out of 14162 females with H8_HL_CON_NAS died.

Males

Parameter HR [95% CI] p-value
H8_HL_CON_NAS 0.964 [0.86, 1.07] 0.505
Birth year 0.984 [0.97, 0.99] 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1735 out of 12076 males with H8_HL_CON_NAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_HL_CON_NAS.

N-year risk Females Males
1 0.099% 0.181%
5 0.629% 0.973%
10 1.507% 2.45%
15 2.841% 4.827%
20 5.133% 8.084%

Relationships between endpoints

↥

Index endpoint: H8_HL_CON_NAS – Conductive hearing loss, unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data